Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.

Higuchi T, Orita T, Katsuya K, Yamasaki Y, Akiyama K, Li H, Yamamoto T, Saito Y, Nakamura M.

Mol Cell Biol. 2004 Sep;24(17):7456-68.

2.

HGF/SF-met signaling in the control of branching morphogenesis and invasion.

Zhang YW, Vande Woude GF.

J Cell Biochem. 2003 Feb 1;88(2):408-17. Review.

PMID:
12520544
3.

Met receptor tyrosine kinase: enhanced signaling through adapter proteins.

Furge KA, Zhang YW, Vande Woude GF.

Oncogene. 2000 Nov 20;19(49):5582-9. Review.

4.

HGF: a multifunctional growth factor controlling cell scattering.

Stella MC, Comoglio PM.

Int J Biochem Cell Biol. 1999 Dec;31(12):1357-62. Review.

PMID:
10641789
5.

Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins.

Gotoh N.

Cancer Sci. 2008 Jul;99(7):1319-25. doi: 10.1111/j.1349-7006.2008.00840.x. Epub 2008 Apr 29. Review.

6.

Met, metastasis, motility and more.

Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.

Nat Rev Mol Cell Biol. 2003 Dec;4(12):915-25. Review. No abstract available.

PMID:
14685170
7.

Scatter factor receptors are key players in a unique multistep program leading to invasive growth.

Bardelli A, Comoglio PM.

Ciba Found Symp. 1997;212:133-44; discussion 144-7. Review.

PMID:
9524768
8.

HGF controls branched morphogenesis in tubular glands.

Maffè A, Comoglio PM.

Eur J Morphol. 1998 Aug;36 Suppl:74-81. Review.

PMID:
9825897
9.

Aspects of growth factor signal transduction in the cell cytoplasm.

Panaretto BA.

J Cell Sci. 1994 Apr;107 ( Pt 4):747-52. Review. No abstract available.

10.

Gab1, SHP-2 and other novel regulators of Ras: targets for anticancer drug discovery?

Yart A, Mayeux P, Raynal P.

Curr Cancer Drug Targets. 2003 Jun;3(3):177-92. Review.

PMID:
12769687
11.

Sprouty: how does the branch manager work?

Guy GR, Wong ES, Yusoff P, Chandramouli S, Lo TL, Lim J, Fong CW.

J Cell Sci. 2003 Aug 1;116(Pt 15):3061-8. Review.

12.

Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.

Proud CG.

Cardiovasc Res. 2004 Aug 15;63(3):403-13. Review.

PMID:
15276465
13.

How to make tubes: signaling by the Met receptor tyrosine kinase.

Rosário M, Birchmeier W.

Trends Cell Biol. 2003 Jun;13(6):328-35. Review.

PMID:
12791299
14.

HGF/SF-Met signaling in tumor progression.

Gao CF, Vande Woude GF.

Cell Res. 2005 Jan;15(1):49-51. Review.

16.

C-MET as a new therapeutic target for the development of novel anticancer drugs.

Cañadas I, Rojo F, Arumí-Uría M, Rovira A, Albanell J, Arriola E.

Clin Transl Oncol. 2010 Apr;12(4):253-60. doi: 10.1007/s12094-010-0501-0. Review.

PMID:
20462834
17.

Help from within: cardioprotective properties of hepatocyte growth factor.

Dixon IM.

Cardiovasc Res. 2001 Jul;51(1):4-6. Review. No abstract available.

PMID:
11399240
18.

Hepatocyte growth factor and Met in drug discovery.

Sakai K, Aoki S, Matsumoto K.

J Biochem. 2015 May;157(5):271-84. doi: 10.1093/jb/mvv027. Epub 2015 Mar 13. Review.

PMID:
25770121
19.

Modular binding domains in signal transduction proteins.

Cohen GB, Ren R, Baltimore D.

Cell. 1995 Jan 27;80(2):237-48. Review. No abstract available.

20.

Supplemental Content

Support Center